Dr. Adi Elkeles is a senior executive with a proven track record in leading biomed entrepreneurship and innovation for 20 years. Till recently, Dr. Elkeles served as VP Business Development for life sciences at Ramot, where he led the business development, licensing and strategy for the life science sector. Before joining Ramot, he was Chief Technology Officer and Chief Business Development Officer at Micromedic, a cancer diagnostic cluster company, where he led commercialization, in licensing and out licensing activities. Previously, Dr. Elkeles served as CEO of Zetiq Technologies Ltd., a cancer diagnostic company, where he evolved the company from a pre-clinical stage to having a fully commercial product and a portfolio of pipeline products in clinical stage. Prior to joining Zetiq, Dr. Elkeles held several managerial positions, leading pre-clinical development programs for anti-cancer at BiolineRx technology incubator and infectious diseases at XTLbio.
Dr. Elkeles holds a PhD degree from Tel Aviv University, an MBA from the College of Management, and has completed a post-doctoral fellowship at the Weizmann Institute of Science. He is an alumnus of the Paul Merage life science executive leadership program at UC Irvine, California.